查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404601

水腫臨床試驗市場規模、佔有率、趨勢分析報告：按階段、按市場參與企業、按研究設計、按類型、按地區、按細分市場、預測，2023-2030 年

Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Participant, By Study Design, By Type, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

水腫臨床試驗市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球水腫臨床試驗市場規模將達到12.7億美元，2023年至2030年複合年成長率為5.7%。

推動市場成長的一些因素包括心臟衰竭、腎功能不全和肝硬化等基礎疾病導致的水腫盛行率增加，以及醫學研究中醫療開發支出的增加。

此外，水腫研究預計將推動市場擴張。例如，2021 年 8 月，諾華宣布 Beovu 治療糖尿病黃斑部水腫的 III 期試驗取得了令人鼓舞的結果，給藥給藥長達 16 週，顯示出有效結果。 KITE 試驗第 2 週和第 100 週的結果顯示，大多數完成負荷階段和第一個 12 週週期的患者仍保持 12 或 16 週的給藥間隔，直到研究結束。

水腫臨床試驗市場報告亮點

  • 這是因為 II 期階段涉及對更多患者進行更廣泛的測試，以評估療效和安全性。此類試驗旨在完善給藥、確定副作用並收集治療效果的初步證據。
  • III 期細分市場預計複合核准為 5.5%。
  • 根據參與者的數據，2022 年成人細分市場佔據最大的銷售佔有率，達到 48.9%。這是因為成人部分可能有更長的病歷，並且就其起源和嚴重程度而言是一個更加多樣化的人群。
  • 根據試驗設計，介入試驗部分預計將在 2022 年佔據最大的收益佔有率，達到 48.2%，並在預測期內以 5.8% 的最快複合年成長率成長。該設計吸引了來自多個國家和地區的參與者，並且經常採用多中心方法。
  • 按類型分類，局部水腫細分市場在 2022 年佔據最大收益佔有率，達到 63.5%。某些族群局部水腫的頻率和強度將增加其在特定地區和醫療機構的臨床試驗中的重要性。
  • 2022年，北美以41.4%的銷售佔有率主導市場。因為北美由學術機構、研究設施和臨床試驗地點組成。它還擁有先進而強大的研究基礎設施。預計亞太地區在預測期內將以 6.1% 的複合年成長率最快成長，中國和印度等國家將成為重要的藥品生產和研究中心。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢及展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 營商環境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章階段業務分析

  • 水腫臨床試驗市場：2022 年和 2030 年階段變異分析
  • 第一階段
    • 第一市場，2018-2030
  • 第二階段
    • 二期市場，2018-2030
  • 第三階段
    • 三期市場，2018-2030
  • 第四階段
    • 第四期市場，2018-2030

第5章 參與者業務分析

  • 水腫臨床試驗市場：2022 年和 2030 年參與者變異分析
  • 小兒科
  • 成人
  • 老年醫學

第6章 保薦人業務分析

  • 水腫臨床試驗市場：申辦者變異分析，2022 年及 2030 年
  • 製藥公司
    • 醫藥市場，2018-2030
  • 學術機構
    • 學術市場，2018-2030
  • 政府機關
    • 政府市場，2018-2030

第 7 章 類型業務分析

  • 水腫臨床試驗市場：類型變異分析，2022 年和 2030 年
  • 全身水腫
  • 局部水腫

第8章區域業務分析

  • 區域市場簡介
  • 北美洲
    • 北美水腫臨床試驗市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲水腫臨床試驗市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區水腫臨床試驗市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲水腫臨床試驗市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA 水腫臨床試驗市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭形勢

  • 公司分類
  • 策略規劃
    • 獲得
    • 合作
    • 宣布新平台
    • 其他
  • 公司簡介/名單
    • Otsuka Holdings
    • Hoffmann-La Roche
    • Novartis Pharmaceuticals
    • Bayer
    • Genentech, Inc
    • Biogen
    • Johnson &Johnson
    • Merck &Co., Inc.
    • Sanofi SA
    • AstraZeneca plc
    • Bristol Myers Squibb Company
    • GlaxoSmithKline plc
    • AbbVie Inc.
Product Code: GVR-4-68040-117-8

Edema Clinical Trials Market Growth & Trends:

The global edema clinical trials market size is expected to reach USD 1.27 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Several factors driving the growth of the market include the increasing prevalence of edema caused by underlying illnesses such as heart failure, kidney disorders, and liver cirrhosis, increasing expenditures on health care developments in medical research, among others.

In addition, edema research studies are anticipated to fuel the market's expansion. For instance, in August 2021, Novartis announced encouraging findings from Phase III studies of Beovu treating diabetic macular edema, showing effective outcomes at up to 16-week intervals between doses. The KITE study's results from week 100 of the second year showed that most patients who finished the loading phases and the first 12-week cycle were kept on a 12 or 16-week dosing interval until the study's end.

Edema Clinical Trials Market Report Highlights:

  • Based on phase, the phase-II segment accounted for the largest revenue share of 35.7% in 2022, as there is more extensive testing in a larger group of patients to assess both efficacy and safety in the phase-II segment. These trials aim to refine the dosage, identify adverse effects, and gather preliminary evidence of the treatment's effectiveness
  • The phase-III segment is expected to grow at a CAGR of 5.5% during the forecast period, as it is crucial for obtaining regulatory approval to provide strong evidence of a treatment's effectiveness and safety in a large, diverse patient population
  • Based on participant, the adult segment accounted for the largest revenue share of 48.9% in 2022 due to the possibility that they have a more extended history of the condition and a more diverse population regarding its origin and severity
  • Based on study design, the interventional trials segment accounted for the largest revenue share of 48.2% in 2022 and is expected to grow at the fastest CAGR of 5.8% over the forecast period. This design takes people from several countries and areas and frequently uses a multicenter technique
  • Based on type, the localized edema segment accounted for the largest revenue share of 63.5% in 2022. The frequency and intensity of localized edema in some populations would increase its significance in clinical trials for particular geographic areas or healthcare settings
  • In 2022, North America dominated the market with a revenue share of 41.4% as it consists of academic institutions, research facilities, and places for clinical trials. It also offers an advanced and robust research infrastructure. Asia Pacific is anticipated to grow at the fastest CAGR of 6.1% over the forecast period, with countries such as China and India serving as significant centers for pharmaceutical production and research

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Phase Business Analysis

  • 4.1. Edema Clinical Trials Market: Phase Movement Analysis, 2022 & 2030
  • 4.2. Phase I
    • 4.2.1. Phase I Market, 2018 - 2030 (USD Million)
  • 4.3. Phase II
    • 4.3.1. Phase II Market, 2018 - 2030 (USD Million)
  • 4.4. Phase III
    • 4.4.1. Phase III Market, 2018 - 2030 (USD Million)
  • 4.5. Phase IV
    • 4.5.1. Phase IV Market, 2018 - 2030 (USD Million)

Chapter 5. Participant Business Analysis

  • 5.1. Edema Clinical Trials Market: Participant Movement Analysis, 2022 & 2030
  • 5.2. Pediatrics
    • 5.2.1. Pediatric Market, 2018 - 2030 (USD Million)
  • 5.3. Adults
    • 5.3.1. Adults Market, 2018 - 2030 (USD Million)
  • 5.4. Geriatrics
    • 5.4.1. Geriatrics Market, 2018 - 2030 (USD Million)

Chapter 6. Sponsor Business Analysis

  • 6.1. Edema Clinical Trials Market: Sponsor Movement Analysis, 2022 & 2030
  • 6.2. Pharmaceutical Companies
    • 6.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic Institutions
    • 6.3.1. Academic Institutions Market, 2018 - 2030 (USD Million)
  • 6.4. Government Bodies
    • 6.4.1. Government Bodies Market, 2018 - 2030 (USD Million)

Chapter 7. Type Business Analysis

  • 7.1. Edema Clinical Trials Market: Type Movement Analysis, 2022 & 2030
  • 7.2. Systemic Edema
    • 7.2.1. Systemic Edema Market, 2018 - 2030 (USD Million)
  • 7.3. Localized Edema
    • 7.3.1. Localized Edema Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Competitive Scenario
    • 8.5.3. Mexico
      • 8.5.3.1. Mexico Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Competitive Scenario
    • 8.5.4. Argentina
      • 8.5.4.1. Argentina Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.4.2. Key Country Dynamics
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. Otsuka Holdings
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Platform Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Hoffmann-La Roche
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Platform Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Novartis Pharmaceuticals
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Platform Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Bayer
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Platform Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Genentech, Inc
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Platform Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Biogen
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Platform Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Johnson & Johnson
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Platform Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Merck & Co., Inc.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Platform Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Sanofi S.A.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Platform Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. AstraZeneca plc
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Platform Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Bristol Myers Squibb Company
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Platform Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. GlaxoSmithKline plc
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Platform Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. AbbVie Inc.
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Platform Benchmarking
      • 9.3.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Global Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 5 Global Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 6 Global Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Edema Clinical Trial Market by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 10 North America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 11 North America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 12 North America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 14 U.S. Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 15 U.S. Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 16 U.S. Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 18 Canada Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 19 Canada Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 20 Canada Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 23 Europe Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 24 Europe Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 25 Europe Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 27 Germany Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 28 Germany Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 29 Germany Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 30 UK Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 31 UK Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 32 UK Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 33 UK Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 34 France Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 35 France Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 36 France Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 37 France Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 39 Italy Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 40 Italy Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 41 Italy Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 43 Spain Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 44 Spain Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 45 Spain Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 47 Denmark Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 48 Denmark Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 49 Denmark Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 51 Sweden Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 52 Sweden Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 53 Sweden Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 55 Norway Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 56 Norway Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 57 Norway Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 63 China Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 64 China Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 65 China Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 66 China Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 67 Japan Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 68 Japan Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 69 Japan Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 70 Japan Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 71 India Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 72 India Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 73 India Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 74 India Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 76 South Korea Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 77 South Korea Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 78 South Korea Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 79 Australia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 80 Australia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 81 Australia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 82 Australia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 83 Thailand Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 84 Thailand Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 85 Thailand Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 86 Thailand Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 87 Latin America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 89 Latin America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 90 Latin America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 91 Latin America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 92 Brazil Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 93 Brazil Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 94 Brazil Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 95 Brazil Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 96 Mexico Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 97 Mexico Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 98 Mexico Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 99 Mexico Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 101 Argentina Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 102 Argentina Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 103 Argentina Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 111 South Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 112 South Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 117 UAE Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 119 UAE Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 120 UAE Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Edema Clinical Trial Market: Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Edema Clinical Trial Market for Phase I, 2018 - 2030 (USD Million)
  • Fig. 16 Global Edema Clinical Trial Market for Phase II, 2018 - 2030 (USD Million)
  • Fig. 17 Global Edema Clinical Trial Market for Phase III, 2018 - 2030 (USD Million)
  • Fig. 18 Global Edema Clinical Trial Market for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 19 Global Edema Clinical Trial Market for Pediatrics , 2018 - 2030 (USD Million)
  • Fig. 20 Global Edema Clinical Trial Market for Adults, 2018 - 2030 (USD Million)
  • Fig. 21 Global Edema Clinical Trial Market for Geriatrics, 2018 - 2030 (USD Million)
  • Fig. 22 Global Edema Clinical Trial Market for Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 23 Global Edema Clinical Trial Market for Academic Institutions, 2018 - 2030 (USD Million)
  • Fig. 24 Global Edema Clinical Trial Market for Government Bodies, 2018 - 2030 (USD Million)
  • Fig. 25 Global Edema Clinical Trial Market for Systemic Edema, 2018 - 2030 (USD Million)
  • Fig. 26 Global Edema Clinical Trial Market for Localized Edema, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Outlook, 2022 & 2030
  • Fig. 28 North America Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 30 Canada Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 31 Europe Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 32 Germany Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 33 UK Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 34 France Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 35 Italy Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 36 Spain Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 37 Denmark Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 38 Sweden Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 39 Norway Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 41 Japan Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 42 China Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 43 India Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 44 Australia Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 47 Latin America Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 48 Brazil Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 54 UAE Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Edema Clinical Trial Market 2018 - 2030 (USD Million)